cartitiude-1: bcma-targeted car t-cell therapy shows high response rates in patients with multip...
Published 4 years ago • 84 plays • Length 2:45Download video MP4
Download video MP3
Similar videos
-
10:18
ide-cel; bb2121, a bcma-targeted car t-cell therapy, in patients with rrmm: initial karmma results
-
2:55
phe885 car-t cell therapy shows high response rates for r/r multiple myeloma in phase 1
-
8:27
multiple myeloma patients treated with bcma-directed car t-cell therapy have high response rate
-
6:28
phase i crb-402 study of the bcma-targeted car t cell therapy bb21217 in pts w/rr multiple myeloma
-
0:53
incorporating bcma-targeted car-t therapy in the frontline treatment of multiple myeloma
-
4:25
updated results from cartitude-1: phase 1b/2study of cilta-cel in pts with rr multiple myeloma
-
4:25
cartitude-1: jnj-4528, a b-cell maturation antigen (bcma)-directed car-t-cell therapy for r/r mu...
-
5:24
a novel car-t cell therapy targeting bcma is highly effective for pts with relapsed multiple myeloma
-
7:10
bcma-targeted car t-cell therapy for myeloma
-
4:17
clinical outcomes of relapsed/refractory multiple myeloma patients after bcma-targeted car t the...
-
7:42
cartitude-1 results: car-t against bcma in r/r mm
-
4:15
what’s next for bcma-targeted adcs and car-t therapy in rrmm?
-
9:01
updated results of bcma/cd19 dual-targeting fast car-t gc012f dual-targeting car-t in rrmm
-
7:24
updated study results of bcma/cd19 dual-targeting car-t gc012f for rrmm patients
-
3:28
cartitude-1: a phase 1b/2 study of jnj-4528, a car-t cell therapy directed against bcma
-
7:06
efficacy and safety of elranatamab bcma-cd3 bispecific antibody, in patients with rrmm
-
55:48
hitting the bcma target in multiple myeloma
-
2:45
updated results from an ongoing phase 1 clinical study of bb21217 anti-bcma car t cell therapy
-
4:21
phase 1 study phe885 bcma-directed car-t cell therapy for rrmm | adam sperling, md, phd | asco 2023